Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis
This is huge, and you deserve to feel incredible about the progress youre making
Both peptides promote angiogenesis through complementary mechanisms, creating robust vascular networks that support comprehensive tissue regeneration
doi: 10.1080/17425255.2021.1925249
#Biotech #CellTherapy #Diabetes #DrugDevelopment #BiotechInnovation #HealthcareInnovation To view or add a comment, sign in Antibody Therapeutics (IF=4.5, Oxford University Press) Research Highlight - Targeting VCAM-1 for Vascular Inflammation Were highlighting a research article published in Antibody Therapeutics - Volume 8, Issue 4 (October 2025): Assessing the therapeutic potential of a panel of novel VCAM-1 antibodies using microfluidic and three-dimensional in vitro models of vascular inflammation Jessica Pickett, Lucia Zacchi, Binura Perera, YUAO WU, Hang Ta from Griffith University and The University of Queensland Vascular inflammation and leukocyte recruitment play central roles in the development of atherosclerosis
- Injury Repair & Healing: Accelerates recovery
